Compugen Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CGEN | CHRS | PYXS | ADAG | MGNX | PDSB | |
|---|---|---|---|---|---|---|
| Market cap | 196.08M | 159.14M | 240.11M | 183.97M | 236.96M | 110.16M |
| P/E (TTM) | 5.4 | — | — | — | — | — |
| Forward P/E | -5.6 | -1.6 | -1.8 | -4.9 | -2.5 | -4.4 |
| Price/book | 2.2 | 2.6 | 11.2 | 2.1 | 5.5 | -23.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −4.91% | −38.15% | −41.16% | +48.91% | +128.05% | +44.35% |
| Today | −2.82% | −3.74% | −0.99% | −0.72% | −0.53% | +10.14% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CGEN news ›Compugen’s (CGEN) Buy Rating Reiterated at HC Wainwright
Posted by Defense World Staff on Oct 12th, 2026 Compugen (NASDAQ:CGEN – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report released on Monday, Benzinga reports. They presently have a…
Compugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements Transcript
Compugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements October 5, 2026 8:00 AM EDT Eran Ophir - CEO, President & DirectorSharon Kredo-Russo - Senior Vice President of Research &…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.